Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV001752628 | SCV001997534 | uncertain significance | not provided | 2024-05-14 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this variant does not alter splicing |
| Ambry Genetics | RCV002386529 | SCV002695634 | likely benign | Cardiovascular phenotype | 2021-05-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Fulgent Genetics, |
RCV002477970 | SCV002780490 | uncertain significance | Noonan syndrome 1; Juvenile myelomonocytic leukemia; Metachondromatosis; LEOPARD syndrome 1 | 2022-01-07 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV003539405 | SCV004343882 | likely benign | RASopathy | 2025-01-12 | criteria provided, single submitter | clinical testing | |
| Women's Health and Genetics/Laboratory Corporation of America, |
RCV004699460 | SCV005205331 | likely benign | not specified | 2024-06-04 | criteria provided, single submitter | clinical testing |